Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | IGF2R | P11717 | 1/20 | 0.43 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.42 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.42 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.42 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1428736 | 1.00 | L3MBTL1 (0.47) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL1521482 | 1.00 | L3MBTL1 (0.47) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL7549069 | 1.00 | L3MBTL1 (0.47) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL1521605 | 1.00 | L3MBTL1 (0.47) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL1521238 | 1.00 | L3MBTL1 (0.47) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL7085810 | 1.00 | L3MBTL1 (0.47) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL1428932 | 1.00 | L3MBTL1 (0.47) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL7550353 | 1.00 | L3MBTL1 (0.47) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL1521126 | 1.00 | L3MBTL1 (0.47) | L3MBTL1GAATYRMAPTPTPN1 | |
| SCHEMBL1521275 | 1.00 | L3MBTL1 (0.47) | L3MBTL1GAATYRMAPTPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002048331-A2 | ACTIVE-SITE ENGINEERING OF NUCLEOTIDYLTRANSFERASES AND ENZYMATIC METHODS FOR THE SYNTHESIS OF NATURAL AND 'UNNATURAL' UDP- AND NUCLEOTIDE SUGARS | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2002-06-20 | — | — | WO | disclosed |
| WO-1992003122-A1 | PREPARATION FOR APPLICATION OF ACTIVE SUBSTANCES IN THE FORM OF MINIMUM-SIZED DROPLETS | CEVC GREGOR (DE) | 1992-03-05 | — | — | WO | disclosed |
| US-4792615-A | HYDROLYSIS OF A-DIHYDROPOLYPRENYL DICHLOROPHOSPHATE WITH ALKALI OR ALKALINE EARTH METAL HYDROXIDE; POLYISOPRENE | NAKAGAWA NAOSHI (JP) | 1988-12-20 | — | — | US | disclosed |